In PB T cells, similar to B cells, whether for CTLA-4 or for BTLA, the median mRNA expression levels in the CLL patients were higher than those in the controls (p = 0.000001 and p = 0.000001, respectively; Figure 4). The gene discussed is BTLA; the disease is B-cell chronic lymphocytic leukemia.